Back to Search
DONNA METZ, PHD
PHD
Research Study Specialist
NPI: 1467785238Individual
Specialties, Licenses & Credentials
Research Study SpecialistPrimary
Specialist — Research Study
Code: 1744R1102X
Research & Publications (20)
[Resistance to platelet antiaggregants: the cardiologist's point of view].
PMID 19128908·J Mal Vasc·2009
6-review
Defining dose-response relationships in the therapeutic blockade of B7RP-1-dependent immune responses.
PMID 19292985·Eur J Pharmacol·2009
7-preclinical
Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions.
PMID 16423003·Aliment Pharmacol Ther·2006
3-trial
Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
PMID 12591045·Am J Gastroenterol·2003
8-other
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
PMID 11774936·Am J Gastroenterol·2001
8-other
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
PMID 10710049·Am J Gastroenterol·2000
3-trial
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis.
PMID 19210298·Aliment Pharmacol Ther·2009
3-trial
Financial impact of coronary stenting in emergency for acute coronary syndromes.
PMID 19520326·Arch Cardiovasc Dis·2009
4-observational
The impact of temperature on the performance of anaerobic biological treatment of perchlorate in drinking water.
PMID 19249808·Water Res·2009
8-other
B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells.
PMID 19155489·J Immunol·2009
7-preclinical
Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.
PMID 19298580·Aliment Pharmacol Ther·2009
6-review
Minimal extracorporeal circulation and off-pump compared to conventional cardiopulmonary bypass in coronary surgery.
PMID 19671581·Interact Cardiovasc Thorac Surg·2009
4-observational
Suprasegmental characteristics of speech produced during simultaneous communication by inexperienced signers.
PMID 19056859·J Deaf Stud Deaf Educ·2009
4-observational
Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography.
PMID 19442886·J Am Coll Cardiol·2009
4-observational
Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor.
PMID 18924259·Am J Gastroenterol·2008
8-other
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.
PMID 18703061·Gastroenterology·2008
6-review
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
PMID 18321037·J Med Chem·2008
7-preclinical
Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
PMID 18294109·Pharmacotherapy·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 S FREMONT AVE, UNIT 8 BLDG-A4, ROOM 4101
ALHAMBRA, CA 91803 - Phone
- (626) 457-6631
Quick Facts
- NPI
- 1467785238
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile